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Effect of dialysate composition on intercompartmental fluid shift and
hemodynamics was studied in 12 patients during 1.5 or 2 hours of
hemodialysis without net ultrafiltration, using high (H;Na 154
mmol/Iiter), normal (N;Na 140 mmol/liter) or low (L:Na 126 mniol/liter)
concentration dialysate. H dialysate was associated with a small (0.9%)
increase in blood volume, a larger increase in plasma volume and a
decrease in erythrocyte volume. L dialysate resulted in a 2.3% decrease
in blood volume, a larger decrease in plasma volume and an increase in
erythrocyte volume. N dialysate gave results which were intermedi-
ately between the other two dialysis conditions. There was no differ-
ence in the post-dialysis mean arterial pressure between the groups,
although heart rate increased more during H dialysis than during the
other two conditions. Change in blood and erythrocyte volume corre-
lated significantly with change in plasma Na concentration and osmolal-
ity, but not with change in plasma urea concentration. We conclude that
dialysate composition affects the movement of water into and out of the
plasma and erythrocytes in a manner that can be accounted for by
altered plasma concentrations of osmotically active substances.
Several studies have shown that the frequency and severity
of dialysis related symptoms, such as hypotension and cramps,
can be reduced by raising the dialysate sodium (DNa) concen-
tration [1—4]. This is believed to result, at least in part, from
more efficient plasma refilling consequent upon an elevation of
plasma osmolality (Posm) which promotes mobilization of fluid
from the extravascular into the vascular space. Studies during
hemodialysis, with and without net fluid removal, give some
support to this concept but have, to date, been less than
satisfactory in their design and execution and have employed
methods for measuring change in fluid compartment volumes
which are open to criticism. It is not, therefore, surprising that
confusing results have been published as to the presence and
extent of change in blood volume (BY) when DNa has been
varied from low to high concentration. For example, no change
in BY was found in one study when DNa was changed from 133
to 140 mmol/liter [1] while in another low DNa was associated
with a significant decrease in plasma volume (PY) while high
DNa had an insignificant effect [4].
To avoid these criticisms we have studied patients during
hernodialysis without net fluid removal and have employed
methods to measure change in blood and plasma volumes which
do not require the use of radioisotopes. Our results confirm that
during hemodialysis without net convective transport of fluid
across the dialysis membrane, change in DNa affects intravas-
cular volume in a qualitatively predictable manner.
Methods
Patients
Six male and six female, stable hemodialyis patients, median
age 49 years (range 23 to 59), were studied after having given
informed consent. Median time on hemodialysis was five
months (range I to 118). One patient had taken 10 mg of
prednisolone for three months but no other took medication
known to affect the cardiovascular system. Patients were nei-
ther fluid overloaded nor depleted and passed less than 400 ml
of urine per day. Primary renal disease was polycystic kidney
disease (3 patients), glomerulonephritis (2) systemic lupus
erythematosis (2), atrophic pyelonephritis (2), hypertensive
nephropathy (1), polyarteritis (1) and congenitally small single
kidney (1).
Dialysis conditions
Patients underwent conventional twin needle dialysis on a 1
m2 hollow—fiber cuprophane dialyzer (Dylade Cl) with
extracorporeal blood flow rates between 200 and 250 mllmin
and dialysate flow of 500 ml/min. Anticoagulation was by
routine systemic heparinization. The automatic supply unit
(Dylade Series E) used employs volumetric control of ultrafil-
tration which allows dialysis to take place without net removal
of fluid. The proportioning pump was calibrated so that dialysis
could proceed against low (L, DNa 126 mmol/liter), normal (N,
DNa 140 mmol/liter), or high (Fl, DNa 154 mmol/liter) concen-
tration dialysate. N concentration dialysate also contained: K
1.43 mmol/liter, Ca 1.73 mmol/liter, Mg 0.54 mmol/liter, acetate
37.4 mmol/liter, Cl 108 mmol/liter, and dextrose 1.92 g/liter.
Alterations in dialysate Na concentration result in a propor-
tional change in the concentration of all these substances.
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Study design
Each patient was studied during three consecutive dialyses at
two to three day intervals, and a different concentration dialy-
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sate was used on each occasion. They refrained from eating,
drinking, or smoking and remained supine from one hour before
connection to the extracorporeal circuit and throughout the
study. Patients were connected to the circuit after the priming
volume of saline was discarded. There followed a 30-minute
equilibration period during which blood but not dialysate circu-
lated, and neither dialysis nor ultrafiltration took place. Blood
was then withdrawn from the "arterial" line for estimation of
water content (3 ml) as well as for plasma osmolality(Posm),
urea(Purea) and electrolytes. Further samples were taken from
patients 8 to 12 for measurement of hemoglobin concentration
(Hb; 1 ml) hematocrit (Hct; I ml), plasma oncotic pressure
(P0) and plasma water content (Cp). Plasma samples were
obtained by decanting the plasma from the red cell layer after
blood had been standing for 20 minutes in sealed sterile con-
tainers. The red cells were then returned to the patient. Dialysis
with no net ultrafiltration was then commenced. Repeat blood
and plasma samples were taken after 90 minutes. The study
period was extended to two hours for patients 8 to 12, after
which time further blood and plasma samples were taken.
Measurements
Body weight was recorded continuously with bed scales
(Datex) and the study repeated on a subsequent day if body
weight varied more than 100 grams during the experiment.
Systolic and diastolic blood pressure (BP) and heart rate (HR)
were monitored at five minute intervals from the start of the
equilibration period using the Critikon Vital Signs Monitor,
which measures BP oscillometrically and displays the results
digitally. Mean arterial pressure (MAP) was calculated as 1/3
systolic + 2/3 diastolic BP. Mean BP and I-JR measurements
obtained during the last 15 minutes of the equilibration and
experimental dialysis periods were used for analysis of results.
Nadir MAP was the lowest MAP recorded at any stage during
the experimental dialysis period.
Plasma and dialysate urea and electrolytes were measured by
autoanalyzer and osmolality by freezing point depression (Ad-
vanced Instruments, Inc.). Hct was taken as the mean of six to
eight readings obtained using a direct microhematocrit method
after centrifugation for ten minutes and correction for 1.8%
trapped plasma [51. Hb was measured on a Coulter-S counter
(Coulter Electronics, Hileah, Florida, USA) and Mean Cor-
puscular Hemoglobin Concentration (MCHC) calculated as
Hb/Hct. P01 was measured with an oncometer incorporating an
Amicon PM-30 membrane (Amicon, Lexington, Massachu-
setts, USA).
Blood water content (CBW). After collection into heparinized
tubes blood was mixed for at least 30 minutes. It was then
drawn up into a platform mounted syringe pipette and aliquots
of approximately 0.6 ml delivered into wide-necked glass bot-
tles. The syringe pipette was calibrated using distilled water so
that the true volume of each sample could be obtained after
weighing. CBW was determined by weighing the bottle of blood
before and after drying in an oven at 105° for 12 hours and
expressed as gH2O/ml blood. The mean of three readings of
CBW obtained from each sample was used.
Blood volume (BV) change, Assuming that BV changes only
as a result of water shift and that the fraction of the total blood
volume removed for sampling is insignificant, the volume of
blood at time t (BY) expressed as a proportion of the volume at
time 0 (By0) is given by:
BV (1 — CBWO) (1)
BY0 (1 — CBWt)
where CBWO and CBW are values of CBW at time 0 and t,
respectively, (Appendix). The accuracy with which BY change
in vitro can be monitored by serial blood water estimations is
discussed by Greenwood, Aldridge and Cattell [6].
Plasma water content (Cp) and plasma volume (PV)
change. Cpw was measured in a similar manner to CBW by
weighing a standard aliquot of plasma before and after it was
dried in an oven for 12 hours. An expression relating PV at time
(PVc) to its starting value (PY0) can be derived making the
same assumptions as for the calculation of relative BY:
pv = (1 — Cpw0) (2)
PV0 (1 — Cp)
where o and refer to values at time 0 and t, respectively.
Change in erythrocyte volume (EV). This was calculated from
change in MCHC. Since total mass of hemoglobin = MCHC x
EV, for hemoglobin mass balance
MCHCO x EV0 = MCHC x EY
EV MCHCO (3)EV0 MCHC
where and refer to values at time 0 and t, respectively.
Erythrocyte water content (CEW). If it is assumed that the
water in blood is contained in plasma and red cells alone, then
the mass of water contained in whole blood, (BY CBW) is
given by:
BV Cw = PY- Cpw + EV - CEW
= BV- (1 — Net) Cpw + BY Net- CEW
or CEW = CBW
— CPw + Cpw - Hct (4)
Hct
Statistics
Analysis of variance (F ratio) ws used for the initial com-
parison of group means under the three experimental condi-
tions, with subsequent between group comparisons carried out
using Student's t-test for paired data. Correlation coefficients (r
values) were calculated by linear regression.
Results
Mean biochemical and hemodynamic data for the 12 patients
before dialysis with H, N, and L concentration dialysate are
shown in Table 1. There were no significant differences before
treatment in CBw, Osm, Purea, PNa, BP or HR. Post-dialysis
values are displayed in Table 2. The three dialysates resulted in
significantly different values for C8, POsm and PNa, but not
Purea which fell a similar amount under the three experimental
conditions.
On average MAP fell significantly (5.5 mm Hg, t = 2.32, P <
0.025) during experimental dialysis. However there was no
significant difference between the post-dialysis BP (systolic,
diastolic or MAP) resulting from the use of the different
or
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Table 1. Mean (SD) predialysis biochemical and hemodynamic data, N = 12
Dialysate concentration Between groups
H N L Fratio P
C gimI 0.8841 (0.0104) 0.8832 (0.0122) 0.8821 (0.004) 0.0 NS
Posm mOsm/kg 302.4 (7.9) 303.5 (9.0) 304.0 (8.0) 0.1 NS
Pura mmol/liter 22.1 (5.5) 22.4 (8.1) 22.7 (5.7) 0.0 NS
PNs mmol/liter 138.9 (2.0) 139.3 (2.2) 139.3 (2.2) 0.2 NS
BP mm Hg
systolic 154.1 (21.0) 148.2 (19.1) 153.4 (20.7) 1.0 NS
diastolic 89.7 (13.9) 86.3 (12.3) 89.3 (11.7) 0.9 NS
MAP Ill.! (14.8) 106.9 (11.9) 110.7 (12.5) 1.0 NS
HR mi,r' 76.3 (14.4) 80.9 (19.7) 79.1 (14.2) 1.3 NS
Table 2. Mean (SD) biochemical and hemodynamic data after 1.5 hours experimental dialysis, N = 12
Dialysate concentration Between groups
H N L Fratio P
CBW g/ml 0.8851 (0.0109) 0.8826 (0.0127) 0.8793 (0.0110) 33.0 <0.001
POsm mOsmlkg 301.7 (6.4) 293.3 (7.0) 283.1 (6.6) 25.1 <0.001
Pura mmo//ljter 14.2 (3.7) 14.4 (4.9) 14.5 (3.5) 0.0 NS
PNa mmol/ljter 143.8 (1.5) 139.3 (1.6) 134.7 (2.2) 106.7 <0.001
BP mm Hg
systolic 152.0 (25.0) 145.4 (23.1) 148.1 (21.3) 0.90 NS
diastolic 82.1 (13.5) 81.1 (12.8) 85.4 (12.2) 1.40 NS
MAP 105.2 (15.2) 102.0 (14.9) 105.2 (15.2) 1.20 NS
Nadir MAP 97.6 (14.4) 97.1 (11.9) 101.0 (11.2) 1.50 NS
HR min' 89.8 (16.7) 89.4 (18.6) 84.2 (15.4) 4.54 <0.05
concentration dialysates. Similarly, there was no difference
between the nadir MAPs.
Post-dialysis HR varied with dialysate concentration as did
dialysis—induced change in HR (F = 10.63, P < 0.001). The
increase in HR following H concentration dialysis (13.5 min)
was significantly greater than the 8.5 mm increment obtained
with N (t = 2.48, P < 0.05) or the 5.1 min increase observed
with L concentration dialysis (t 6.63, P < 0.001). There was
no significant difference between the HR change observed with
L and N dialysate (t = 1.6, P> 0.1).
CBW after 90 minutes dialysis differed with dialysate concen-
tration as did the percent of change in BV (F = 10.55, P <
0.001; Fig. 1). BV increased an average 0.9% during H concen-
tration dialysis and decreased 0.5% and 2.3% during N and L
concentration dialysis, respectively. There were significant
differences between BV response to H and N concentration
dialysate (t = 1.97, P < 0.05) and between N and L (t = 2.62,
P < 0.025).
Percentage change in BV correlated significantly with the
percent of change in POsm (r = 0.53, P < 0.001; Fig. 2) and PNa
(r = 0,52, P < 0.001; Fig. 3), but not with change in Purea (r
—0.15, P > 0.1).
Results from the extended study are summarized in Table 3.
Change in EV calculated from change in MCHC correlated
closely with change in CEW (r = 0.89, P < 0.001; change in EV
0.0 + 2.22 change in CEW). Because of the small number of
patients involved [5], statistical analysis was not carried out on
between group differences. H concentration dialysis is associ-
ated with an increase in By, a greater increase in PV and a
decrease in EV. L concentration dialysate causes a decrease in
BY, a bigger decrease in PV and an increase in EV. N
concentration dialysate gives results intermediate between
those obtained using H and L.
There was a highly significant negative correlation between
the percent change of P01 and percent change in with
increases in being associated with decreases in P0 (r =
—0.89, P < 0.001, Fig. 4).
The percent change in EV correlated with percent change in
PNA (r = —0.81, P < 0.001; Fig. 5) and POsm (r = —0.81, P <
0.001; Fig. 6) but not with change in Purea (r = —0.15, P >0.1).
A rise in Osm or PNa is associated with shrinkage of erythro-
cytes, while a decrease in these variables is associated with
erythrocyte swelling.
Discussion
Hypotension occurs commonly during hemodialysis and has
been attributed to both reduction in BY [7] and to hemodynamic
changes, such as a failure of peripheral vascular resistance to
increase during dialysis [8] or depression of cardiac contractility
[9]. Reduction in BY can be induced by removal of plasma
water in excess of plasma refilling from extravascular sites. The
main driving force for plasma refilling during dialysis and
ultrafiltration is elevation of plasma osmotic pressure. Methods
designed to increase POsm during hemodialysis and ultrafiltra-
tion such as increasing DNa [2, 3], administration of Dextran [7]
or mannitol [10] have all been used successfully to reduce some
dialysis related symptoms.
Studies examining intercompartmental fluid shifts during
hemodialysis and ultrafiltration under differing conditions of
DNa concentrations are difficult to perform. For fair comparison
Fig. 1. Percent change in blood volume (BV) after 1.5 hours treatment
with high (H), Normal (N) and Low (L) concentration dialysate.
Different symbols refer to data obtained from individual subjects, N =
12.
it is essential that identical amounts of fluid are removed under
the different experimental conditions. Examination of published
results [4, 11, 12] indicates that this has not always been
achieved. In some cases [11, 121 intravenous fluids were admin-
istered during the study in an attempt to ensure that identical
amounts of fluid were removed under the different experimental
conditions, but this in itself must prejudice the interpretation of
results. For this reason we chose to study the effect of varying
dialysate concentration on circulating blood and plasma volume
when there was no net removal of fluid which we confirmed by
body weight changes of less than 100 grams during the experi-
ment.
A second problem with previous studies has been the doubt-
ful validity of using radioisotope techniques to measure PV
and/or extracellular fluid volume before and after dialysis and
ultrafiltration [4, 11—131. For this to be valid there must be no
transcellular fluid shifts occurring in the post-dialysis period
[12]. However, it has clearly been shown that plasma refilling
continues for some hours after ultrafiltration has ceased [14].
The inappropriate use of isotopic dilution methods in the
immediate post-dialysis period could account for apparently
anomalous results, such as high DNa with zero ultrafiltration
•
— ;..
—•.
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causing a 1350 ml increase in extracellular fluid (calculated from
pre- and post-dialysis measurement of Na235SO4 space), yet
only a 30 ml increment in PV (calculated from change in serum
albumin concentration) [4].
A further potential methodological error can arise where
measurement of change in BY or PV is based on change in Hct.
The latter can only be used if it is certain that there has been no
change in EV. We have shown previously [15] that there is
change in EV under changing conditions of plasma sodium
concentration. This is in conflict with previous claims [3, 16]
that erythrocyte volume does not change during hemodialysis
with low as opposed to high DNa.
The present study was designed to avoid these various
problems. To concentrate on the effect of hemodialysis against
low, normal, and high DNa on circulating blood and plasma
volume we chose to eliminate fluid removal by ultrafiltration,
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Fig. 2. Relationship between percent change in plasma osmolality(Pox,,,) and blood volume (By). Data from 1.5 and 2 hours. N = 12.
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Fig. 3. Relationship between percent change in plasma Na(PN) and
blood volume (By). Data from 1.5 and 2 hours. N = 12.
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Table 3. Percent alteration in blood volume (By), plasma volume (PV), erythrocyte volume (EV) and oncotic pressure (P0)
after 1.5 and 2 hours experimental dialysis, N = 5
.
Dialysate
concentration
1.5 hour
% change
s
in
2 hours
% change in
BV PV EV PBV PV EV
H
N
L
+ 1.2
—0.8
—3.0
+4.3
—0.6
—5.2
—4.0
+0.3
+3.1
—3.9
+0.7
+7.5
+2.0
—1.1
—3.2
+3.6 —3.9
—1.5 +0.4
—6.7 + 1.9
—5.0
+1.2
+8.8
low DNa. These changes correlate significantly with change in
POsm and PNa, but not with change in Pureaconcentration.
A possible criticism of the use of blood and plasma water
concentration to study changes in their respective volumes is
our assumption that there is no change in the mass of circulating
erythrocytes or plasma solids during dialysis which would
invalidate the use of equations (1) and (2).
With respect to change in circulating red cell-mass, due to
• -
/oWN, change in the ratio of peripheral to whole blood hematocrit,
• 5 addition or removal of erythrocytes from the peripheral circu-
lation would alter the hematocrit. This could not, however,
alter the MCHC save in the unusual situation of having a
dimorphic population of erythrocytes which have differing
levels of hemoglobination—one population being selectively
added or removed—or where there is acute intravascular
hemolysis. Neither of these situations applied to our patients.
If, therefore, there is a change in peripheral blood to whole
body hematocrit, there is still nevertheless a change in eryth-
rocyte volume. That this is due to change in erythrocyte water
content is supported by the close correlation between change in
EV and CEW. Coexistent change in the ratio of peripheral to
whole blood hematocrit cannot be excluded, but such a change
does not invalidate our observation of change in erythrocyte
water as a factor affecting change in whole blood volume.
With respect to any change in the mass of plasma solids, such
a change would certainly affect and hence the calculated
change in plasma volume. The mass of non-protein, small
molecular weight compounds undoubtedly changes. However,
the close negative correlation between change in P0 and
S
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Fig. 4. Relationship between percent change in plasma water (Cpw)
and oncouic pressure (P,,,5.). N = 5. Data from 1.5 and 2 hours.
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Fig. 5. Relationship between % change in erythrocyte volume (EV)
and plasma Na (PN). N = 5. Data from 1.5 and 2 hours.
thus avoiding difficulties in controlling exactly the amount
removed and the need for intravenous infusion of fluid during
the studies. We have also used a greater difference in DNa (10%)
than other workers.
Our results show that hemodialysis against high DNa results in
a rise in blood and plasma water concentrations whereas their
values fall during haemodialysis against low DNa. Assuming that
change in circulating BY relates purely to change in water
content, we found that BY increases significantly during hemo-
dialysis against high DNa and decreases to a greater degree with
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indicates that any change in the mass of non-protein, small
molecular weight compounds has an insignificant effect on Cp.
Much more important would be any change in the mass of
circulating protein. We know of no data which indicates ingress
or egress of plasma proteins (and especially plasma albumin)
into or out of the circulation during dialysis, and indeed many
previous workers have used change in plasma protein concen-
tration to reflect change in plasma volume during dialysis
experiments [1, 11]. Given our objection to the use of isotope
studies, it is not possible to confirm or exclude any shift in
plasma proteins. Should there be a primary change in circulat-
ing protein mass, the expected change in Cpw and P0, would be
different. Thus, ingress or plasma protein should raise oncotic
pressure and attract water into the circulating plasma while
egress would do the reverse. The effect of this would be to
diminish shifts in water due to change in plasma osmolality.
While such a possibility cannot be refuted, our results indicate
that the major shift of water is in the direction expected from
change in the osmotic effect of sodium chloride.
The finding of a decrease in EV following high sodium
dialysis and an increase with low sodium dialysis results in
significant changes in the ratio of red cell volume to whole blood
volume under the different conditions. Failure to identify this
change in red cell volume invalidates the use of Hct in calcu-
lating change in PV [l5}.
All of these findings confirm the theoretical expectation that
increase in Osm will result in a movement of water into the
vascular compartment while the reverse occurs with a decrease
in P0. The significant correlation between fluid shifts and
change in PNa but not with urea support the belief [12] that
alteration of Purea generates little osmotic gradient because of its
mobility between fluid compartments. It is not possible from
these studies to define movement of water between extra- and
intracellular compartments. The changes in erythrocyte volume
do, however, support the notion that Na induces an osmotic
gradient resulting in change in the ratio of extra- to intracellular
water.
Caution is necessary in extrapolation of these results to
combined hemodialysis and ultrafiltration. While the same
osmotic forces may be expected, the size of fluid shifts will be
conditioned by the rate of fluid removal from the vascular
compartment by ultrafiltration. In addition, an ultrafiltration
induced increase in P01w will to some extent affect fluid shifts as
may change in capillary hydrostatic pressure.
There was no difference in post-dialysis BP between the three
conditions, despite the fact that HR and BV increased more
with H conductivity dialysis than it did under the other two
conditions. In some [1], but not all [4] studies, BP has been
reported to fall less with high DNa than with low under condi-
tions of zero net ultrafiltration. However, the changes in BV are
small and it is not surprising that when they are unaccompanied
by large reductions in BV induced by ultrafiltration, they do not
give rise to different BP responses.
In conclusion, our studies clearly show that dialysate com-
position affects the movement of water into and out of the
plasma and erythrocytes in a manner that can be accounted for
on the basis of altered plasma concentrations of osmotically
active substances.
Appendix
V0 and CBWO are the starting blood volume and blood water
concentrations respectively, and Vt and CBWt the values after
ultrafiltration of water; VUF is the volume of water ultrafiltered;
VaT and C1 are the volume and water content of a blood
sample taken at time T during ultrafiltration.
Assuming blood has a specific gravity of approximately 1.0
and there are multiple blood samples:
Vo — V = VJ + VBTTo
T=t
and, for water mass balance,
V0 CBWO — V = VUF + VBT CBWT
T=o
Substituting for VUF for Equation (1),
V0 CBWO — V1 C81 = V0 — V
T=t T=t
— VBT+ VHTCBWT
T=o To
T=t (1 — CBWT)
V1
V0(l — CBWO)
— VBT (1 — CBWt)(1 — CBWI) T=o
If the total volume taken for blood sampling is small,
V
—
(1 — CBWO)
V0 (1 — CBWI)
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